Markus Puhlmann

Technik-/Wissenschafts-/F&E-Leiter bei PERSPECTIVE THERAPEUTICS, INC.

Vermögen: 2 Mio $ am 30.04.2024

Health Technology

Consumer Services

Aktive Positionen von Markus Puhlmann

Unternehmen	Position	Beginn	Ende
PERSPECTIVE THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	-	-

Unternehmen	Position	Beginn	Ende
SEAGEN INC.	Corporate Officer/Principal	01.01.2019	01.01.2022
MERCK & CO., INC.	Corporate Officer/Principal	01.01.2015	01.01.2019

Ludwig-Maximilians-Universität München	Doctorate Degree
McDonough School of Business	Masters Business Admin

International

Vereinigte Staaten	5
Deutschland	2

Operativ

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Sektoral

Health Technology	4
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
PERSPECTIVE THERAPEUTICS, INC.	Health Technology
MERCK & CO., INC.	Health Technology

Private Unternehmen	1
Seagen Inc. Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.	Health Technology

Private Unternehmen

Health Technology